News
Revisions to classification criteria ‘will ensure homogeneous trial populations’ with data-driven scoring, a standardized MRI ...
James Caruso; President, Chief Executive Officer, Director; Cellectar Biosciences Inc. Chad Kolean; Chief Financ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback